We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
19.00 | 1.07% | 1,799.50 | 1,796.00 | 1,796.50 | 1,799.50 | 1,780.00 | 1,784.00 | 9,804,173 | 16:35:21 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 15.00 | 73.94B |
Date | Subject | Author | Discuss |
---|---|---|---|
31/3/2020 09:44 | SNG doing well. Clinical trials.stary yoday in 100 Covid patients | cambourne | |
31/3/2020 08:11 | Trump and J&J seem to be a long way behind the curve? | tradermichael | |
31/3/2020 07:46 | Status of COVID-19 As of 19 March 2020, COVID-19 is no longer considered to be a high consequence infectious diseases (HCID) in the UK. The 4 nations public health HCID group made an interim recommendation in January 2020 to classify COVID-19 as an HCID. This was based on consideration of the UK HCID criteria about the virus and the disease with information available during the early stages of the outbreak. Now that more is known about COVID-19, the public health bodies in the UK have reviewed the most up to date information about COVID-19 against the UK HCID criteria. They have determined that several features have now changed; in particular, more information is available about mortality rates (low overall), and there is now greater clinical awareness and a specific and sensitive laboratory test, the availability of which continues to | johncasey | |
30/3/2020 18:45 | Timelines more realistic if all goes well: "The Trump Administration signed a contract with Johnson & Johnson's pharmaceutical branch. J&J will get $450 million from the government and, combined with its own funding, $1 billion will go to the vaccine development. Already, Moderna has begun trials for its COVI-19 vaccine, but Johnson & Johnson said its own human trials will start by September. It anticipates making one billion doses of the experimental vaccine by 'early 2021,' despite the fact it's only just announced a lead candidate vaccine". | alphorn | |
26/3/2020 14:34 | Resistance and psychology level is 1500p, got to break and hold at close, if they do 1575p here we come. | montyhedge | |
26/3/2020 14:22 | 1575p is a given in my book. A couple of decent days all we need. | montyhedge | |
26/3/2020 14:07 | I'm not trusting it either. | patientcapital | |
26/3/2020 14:06 | Nice turnaround on ftse 100. GLA | daveboy1 | |
26/3/2020 14:00 | It looks like a bear market rally to me, but then if any of us knew the future I doubt we would be posting on a free BB ). | essentialinvestor | |
26/3/2020 13:46 | Yep, negative cynic. Surplus to requirements. | daveboy1 | |
26/3/2020 13:35 | Gawd now he's on about the sky falling in!What a manic depressive!!spud | spud | |
26/3/2020 13:16 | We are in the phoney war....think 1940 before the blitz. Soon, the sky will fall in on the market as USA realises covid isn't just for poor asians. | zicopele | |
26/3/2020 12:54 | For what its worth my bond has recovered from about two days ago | hernando2 | |
26/3/2020 12:43 | Looking at market behaviour it seems investors are selling GSK and buying into stocks that have fallen big time,is this a good move? | abdullla | |
25/3/2020 16:50 | Monty...maybe or maybe not. Depends in USA covid severity. | zicopele | |
25/3/2020 16:22 | Soon be back to 1550p. | montyhedge | |
25/3/2020 16:05 | Haha..alphorn. Please dont conflate a high share price with a societal requirement for good medication. You want this baby to fly so you can make lots of lolly. The drugs are an afterthought | zicopele | |
25/3/2020 16:00 | z - sometimes it is worth just remembering what Pharma does - if you suffer from a potentially serious illness (eg asthma) then Pharma products have truly changed your life. I hope that you never get ill. | alphorn | |
25/3/2020 15:56 | Repent! The end of the world is nigh... Strewth!! spud | spud | |
25/3/2020 15:56 | And you was on here back then ! | amaretto1 | |
25/3/2020 15:24 | Interesting to remember that the unprecedented speed in work identifying a vaccine is in large part to early Chinese efforts to sequence the genetic material of Sars-CoV-2, the virus that causes Covid-19. China shared that sequence in early January, allowing research groups around the world to grow the live virus and study how it invades human cells and makes people sick. Research by groups on earlier outbreaks (eg SARS) was shelved when the virus had been contained. Hopefully news by next month. | alphorn | |
25/3/2020 13:03 | I've seen this at under 11 1025 i recall | amaretto1 | |
25/3/2020 13:00 | From memory GSK traded under 12.70 ish early 2018, IF there is a plunge low on the cards, that area might be tested imv. GSK, all things being equal, should significantly outperform cyclicals in a bear market. Luck with your holdings. | essentialinvestor |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions